This CTD dossier owner and manufacturer is a large, fast-growing pharmaceutical organization with over two decades of experience. They produce a wide range of generic and specialty medicines targeting various therapeutic areas, including infectious diseases, inflammatory skin disorders, and cardiovascular health. Their product portfolio includes prescription medications, oral emulsions, syrups, and suspensions. The company holds several GMP certifications and has a robust manufacturing infrastructure with state-of-the-art formulation units and a vast distribution network spanning across the EU and North America. They are also actively expanding into emerging markets in Asia and Latin America.